卡博赞提尼布加上阿特佐利祖马布治疗晚期肝细胞癌的成本效益分析
Yan Zhu1, Cheng He1, Shi-Chao Cao1
1Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Frontiers in pharmacology
|October 27, 2025
概括
与索拉费尼布相比,卡博赞提尼布加上阿特佐利祖马布在晚期肝细胞癌 (HCC) 治疗中没有证明具有成本效益. 索拉费尼布提供了更好的价值,为HCC患者提供了更大的好处,成本更低.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 晚期肝细胞癌 (HCC) 治疗格局.
- 卡博赞提尼布加上阿特佐利祖马布在延长无进展生存期方面显示出有前途.
- 这种对HCC的组合治疗的成本效益仍然未被评估.
研究的目的:
- 为了评估卡博桑提尼布加上阿特佐利祖马布与索拉费尼布的成本效益.
- 从中国卫生系统和美国纳税人的角度进行分析.
- 评估一线先进HCC治疗的经济结果.
主要方法:
- 基于COSMIC-312试验数据的分区生存模型.
- 从已发表的文献中包括成本和公用事业.
- 质量调整寿命年 (QALYs) 和增量成本效益比 (ICER) 的计算.
- 进行敏感性和子组分析以确保稳定性.
主要成果:
- 卡博桑提尼布加上阿特佐利祖马布产生负ICER,表明索拉芬尼布的成本较低,益处更高.
- 索拉费尼布展示了绝对的主导地位,提供了卓越的成本效益.
- 模型对无进展和整体存活的功用值的最高灵敏度.
结论:
- 卡博赞提尼布加上阿特佐利祖马布不是先进的HCC的成本有效的第一线治疗方法.
- 索拉芬尼布为HCC管理提供了更有利的经济选择.
- 调查结果在中国和美国的付款人观点中是一致的.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.7K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
